1-(tert-Butoxycarbonyl)-2-methylazetidine-2-carboxylic acid, 95.0%, 1g

2-Acetamido-5-nitrothiazole>98.0%(HPLC)(T)1g

5-Me-dC(Ac) amidite, 5g

Sodium 4-methyl-2-oxopentanoate, 95%, 5g

GC capillary column ROTI®Cap-1, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)

5-Amino-1-methyl-1H-tetrazole, 99.0%, 1g

(S)-3-((tert-Butoxycarbonyl)amino)-4,4-dimethylpentanoic acid, 97%, 1g

Acetone, min. 99.5%, for synthesis, 10 l, whitbl.

3-(2-bromophenyl)-1-cyclopropylpiperazine dihydrochloride, 95.0%, 250mg

1,3-Dimethyl-2-oxo-2,3-dihydro-1H-benzimidazole-5-carbaldehyde, 95.0%, 5g

2-methyl-1-propylpiperazine, 95.0%, 1g

4,5,6,7-Tetrahydro-1H-benzo[d]imidazole, 95.0%, 1g

2-Bromoisoindoline-1,3-dione, 95.0%, 1g